Technical Analysis for GGNNW - Genocea Biosciences Inc - Warrants - Class A [09

Grade Last Price % Change Price Change
grade B 0.2 28471.43% 0.1993
GGNNW closed up 28471.43 percent on Thursday, September 5, 2019, on 14 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A N/A Flat
See historical GGNNW trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Gapped Up Strength 0.00%
New 52 Week Closing Low Bearish 28471.43%
Hot IPO Pullback Bullish Swing Setup 28471.43%
Narrow Range Bar Range Contraction 28471.43%
New 52 Week Low Weakness 28471.43%
Gapped Down Weakness 28471.43%
Narrow Range Bar Range Contraction -42.86%
Narrow Range Bar Range Contraction -42.86%
Inside Day Range Contraction -42.86%

Older signals for GGNNW ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer vaccines. The company uses its proprietary discovery platform, ATLAS, to recall a patient's pre-existing CD4+ and CD8+ T cell immune responses to tumor to identify antigens for inclusion in vaccines that are designed to act through T cell (or cellular) immune responses. Its lead immuno-oncology program is GEN-009, an adjuvanted neoantigen peptide vaccine candidate, which is in preclinical stage, designed to direct a patient's immune system to attack tumor. The company is also seeking partners to develop cancer vaccines targeting tumor-associated antigens and a vaccine targeting cancers caused by Epstein-Barr virus. Genocea Biosciences, Inc. was founded in 2006 and is headquartered in Cambridge, Massachusetts.
Medicine Health Medical Specialties Cancer Biopharmaceutical Immunology Cancers Immune System Tumor Cancer Immunotherapy Vaccines Vaccination Cancer Vaccine Antigen
Is GGNNW a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 0 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 0.4
52 Week Low 0.0007
Average Volume 7,113
200-Day Moving Average 0.0
50-Day Moving Average 0.0
20-Day Moving Average 0.0
10-Day Moving Average 0.1996
Average True Range 0.078
ADX 0.0
+DI 52.5622
-DI 45.8638
Chandelier Exit (Long, 3 ATRs ) 0.166
Chandelier Exit (Short, 3 ATRs ) 0.2347
Upper Bollinger Band 0.0
Lower Bollinger Band 0.0
Percent B (%b) 0.0
BandWidth 0.0
MACD Line 0.0106
MACD Signal Line 0.012
MACD Histogram -0.0014
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.2000
Resistance 3 (R3) 0.2000 0.2000 0.2000
Resistance 2 (R2) 0.2000 0.2000 0.2000 0.2000
Resistance 1 (R1) 0.2000 0.2000 0.2000 0.2000 0.2000
Pivot Point 0.2000 0.2000 0.2000 0.2000 0.2000
Support 1 (S1) 0.2000 0.2000 0.2000 0.2000 0.2000
Support 2 (S2) 0.2000 0.2000 0.2000 0.2000
Support 3 (S3) 0.2000 0.2000 0.2000
Support 4 (S4) 0.2000